Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 6.33% vs -6.76% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 13.80% vs -0.84% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -42.39% vs -2.18% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -30.00% vs 3.45% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Nanjing Well Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 6.33% vs -6.76% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 11.16% vs 1.37% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 13.80% vs -0.84% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 21.32% vs 38.75% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -42.39% vs -2.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -34.96% vs 38.60% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -30.00% vs 3.45% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -27.59% vs -19.44% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






